Wet Granulators Market
The market for Wet Granulators was estimated at $523 million in 2024; it is anticipated to increase to $844 million by 2030, with projections indicating growth to around $1.26 billion by 2035.
Report Summary
Market Data
Methodology
Table of Contents
Global Wet Granulators Market Outlook
Revenue, 2024
$523M
Forecast, 2034
$1.16B
CAGR, 2025 - 2034
8.3%
The Wet Granulators industry revenue is expected to be around $566.6 million in 2025 and expected to showcase growth with 8.3% CAGR between 2025 and 2034. Building on this outlook, the wet granulators industry continues to gain importance as pharmaceutical, chemical, and food manufacturers increasingly focus on improving product consistency and process efficiency. Wet granulation technology plays a critical role in enhancing powder flowability, compressibility, and uniformity, which are essential for large scale manufacturing operations. The growing demand for high quality pharmaceutical formulations and the expansion of generic drug production are significantly supporting the adoption of advanced granulation equipment. Additionally, stringent regulatory requirements for product quality and batch consistency are encouraging manufacturers to invest in reliable processing technologies. Continuous advancements in automated processing systems, process monitoring tools, and integrated production lines are further strengthening the relevance of wet granulators across modern industrial manufacturing environments.
Wet granulators are specialized processing machines used to convert fine powders into granules by adding a liquid binder and mechanically mixing the material to form uniform agglomerates. This process improves particle size distribution, flow characteristics, and compressibility, making the material easier to handle in downstream manufacturing stages. Wet granulators are widely used in pharmaceutical tablet production, where they help ensure uniform distribution of active pharmaceutical ingredients and improve tablet strength and stability. They are also applied in the chemical, nutraceutical, and food industries for producing granulated powders used in detergents, fertilizers, and instant food products. Recent trends in the market include the adoption of high shear wet granulators, continuous manufacturing systems, and advanced process control technologies that enhance production efficiency, reduce material waste, and support compliance with strict pharmaceutical quality standards.
Market Key Insights
The Wet Granulators market is projected to grow from $523.2 million in 2024 to $1.16 billion in 2034. This represents a CAGR of 8.3%, reflecting rising demand across Pharmaceutical Manufacturing, Food Processing, and Chemical Industry.
GEA Group, Glatt GmbH, L.B. Bohle are among the leading players in this market, shaping its competitive landscape.
U.S. and Germany are the top markets within the Wet Granulators market and are expected to observe the growth CAGR of 6.1% to 8.7% between 2024 and 2030.
Emerging markets including Indonesia, Brazil and South Africa are expected to observe highest growth with CAGR ranging between 8.0% to 10.4%.
Transition like Transition from Batch Pharmaceutical Processing to Continuous Granulation Manufacturing Systems is expected to add $80 million to the Wet Granulators market growth by 2030.
The Wet Granulators market is set to add $638 million between 2024 and 2034, with manufacturer targeting Capsule Filling & Mixture Blending Application projected to gain a larger market share.
With
technological advancements, and
Regulatory Compliance, Wet Granulators market to expand 122% between 2024 and 2034.
Opportunities in the Wet Granulators
The growing production of generic medicines in emerging economies is also creating a strong opportunity for wet granulators. Countries such as India, China, and Brazil are expanding pharmaceutical manufacturing capacity to meet rising domestic healthcare demand and export requirements. Wet granulators, particularly high shear granulation systems, are widely used in tablet formulation processes because they ensure uniform distribution of active pharmaceutical ingredients and improve powder compressibility. As pharmaceutical companies increase investments in large scale production facilities, demand for automated and high efficiency wet granulation equipment is expected to grow significantly across these rapidly developing pharmaceutical manufacturing hubs.
Growth Opportunities in North America and Asia Pacific
North America represents a technologically advanced market for wet granulators, primarily driven by strong pharmaceutical manufacturing capabilities and strict regulatory standards for drug production. The United States leads regional demand due to its large base of pharmaceutical companies, contract manufacturing organizations, and research driven drug development facilities. Growing adoption of continuous pharmaceutical manufacturing and automated production lines is encouraging investment in advanced wet granulation equipment. Opportunities are emerging from the expanding nutraceutical and dietary supplement sector, where manufacturers require efficient powder processing technologies to ensure product uniformity. The competitive landscape is characterized by established pharmaceutical equipment manufacturers that focus on innovation, regulatory compliance, and integrated production systems. Strategic collaborations between equipment providers and pharmaceutical companies are also increasing as firms seek scalable granulation solutions. Demand for high shear wet granulators and automated processing systems is expected to remain strong as manufacturers prioritize production efficiency and quality assurance.
Asia Pacific is rapidly emerging as a high growth region for wet granulators due to the expansion of pharmaceutical production and increasing investments in generic drug manufacturing. Countries such as India and China are key contributors, supported by strong pharmaceutical export industries and growing domestic healthcare demand. Pharmaceutical manufacturers in the region are upgrading their production infrastructure to meet international quality standards, which is driving demand for modern granulation equipment. The rising number of contract manufacturing organizations and active pharmaceutical ingredient producers further strengthens market potential. Competition in the region includes both global equipment manufacturers and regional suppliers offering cost effective solutions. Opportunities are particularly strong in affordable high shear wet granulators and modular systems designed for medium scale pharmaceutical facilities. Additionally, the expanding nutraceutical and herbal supplement industries across Asia Pacific are encouraging manufacturers to adopt granulation technologies that improve product consistency and processing efficiency.
Market Dynamics and Supply Chain
01
Driver: Growing Demand for High-Quality Pharmaceuticals and Efficient Food Processing Techniques
The rising need for high-quality pharmaceuticals is also a primary driver for wet granulators, as these machines ensure uniform particle size, improved flowability, and accurate dosage in tablets and capsules. Advanced wet granulation techniques, including high-shear and fluid bed granulators, allow pharmaceutical manufacturers to meet stringent regulatory standards while reducing batch failures. Simultaneously, the food processing industry is also adopting wet granulators to produce instant powders, flavorings, and nutritional supplements with improved solubility and consistent particle size. Granulation reduces dust, improves product handling, and enhances shelf life. These twin growth factors stringent quality requirements in pharmaceuticals and efficiency-driven innovation in food processing boost adoption of wet granulators globally. Companies investing in continuous wet granulation processes and integrated drying solutions gain a competitive advantage, supporting scalable production and operational efficiency across niche applications.
Automation and real-time process monitoring are also increasingly shaping wet granulator adoption, allowing precise control of mixing, binder addition, and granule drying. Smart sensors track moisture content, particle size, and temperature, enabling predictive adjustments that reduce waste and improve batch consistency. High-shear and fluid bed granulators integrated with digital monitoring optimize throughput and operational safety while lowering labor dependency. These innovations are also particularly relevant in pharmaceutical and specialty food manufacturing, where product quality, regulatory compliance, and reproducibility are also critical. Adoption of automated, sensor-driven wet granulators enables manufacturers to achieve higher efficiency, reduce downtime, and maintain competitive positioning in rapidly evolving markets.
02
Restraint: High Capital and Operational Costs Deter Adoption by Price‑Sensitive Manufacturers
The significant upfront cost of high‑shear and fluid bed wet granulators limits adoption among small and mid‑sized pharmaceutical, food, and chemical producers. Many producers opt for lower‑cost dry granulation or direct compression methods to preserve capital, which suppresses equipment sales growth. For example, regional generic drug makers may forgo advanced wet granulators to avoid high depreciation and maintenance costs, reducing overall demand. Extended payback periods and increased operational expenses for utilities and skilled operators further slow investment decisions, directly constraining revenue growth for equipment OEMs targeting price‑conscious segments.
03
Opportunity: Growing demand for nutraceutical and functional food granulation processing technologies and Increasing adoption of continuous pharmaceutical manufacturing technologies in regulated markets
The expanding nutraceutical and functional food sector is opening new opportunities for wet granulators used in powder processing and product formulation. Manufacturers producing vitamin supplements, herbal extracts, and protein blends increasingly require granulation systems that improve powder stability, flowability, and dosing accuracy. Wet granulators help convert fine powders into uniform granules that dissolve easily and maintain ingredient consistency in tablets, sachets, and instant drink mixes. Regions such as North America and Asia Pacific are expected to drive growth due to rising consumer interest in health supplements. Compact wet granulators designed for nutraceutical production facilities are likely to experience increasing demand.
A significant opportunity is emerging from the pharmaceutical industry’s transition toward continuous manufacturing systems in regions such as North America and Europe. Regulatory agencies are encouraging advanced manufacturing technologies that improve product consistency, reduce batch variability, and enhance production efficiency. Continuous wet granulators integrated with real time process monitoring and automation platforms are gaining attention among large pharmaceutical manufacturers. These systems enable consistent granule formation while minimizing material loss and production downtime. Demand is expected to be strongest for advanced high shear wet granulators and fluidized wet granulation systems that support fully integrated continuous tablet production lines.
04
Challenge: Skilled Workforce Gaps and Complex Process Requirements Impede Efficient Use
Wet granulation processes demand experienced operators and precise control of multiple variables, including binder addition, moisture, and drying parameters. A lack of trained technicians can lead to inconsistent granule quality, increased batch failures, and production downtime, discouraging investment in advanced systems. For example, a mid‑tier food ingredient manufacturer may experience yield losses due to improper process settings, reducing confidence in automated wet granulators. This skills shortage increases training costs, slows technology adoption, and weakens market growth, particularly in developing regions where technical education and workforce upskilling lag industry needs.
Supply Chain Landscape
1
Raw Material Suppliers
BASFDow Chemicals
2
Component & Parts Manufacturing
General ElectricSiemens
3
Wet Granulators Manufacturing
GEASaintyCoLFA
4
End Users Industry
PharmaceuticalFood ProcessingChemical Industries
1
Raw Material Suppliers
BASFDow Chemicals
2
Component & Parts Manufacturing
General ElectricSiemens
3
Wet Granulators Manufacturing
GEASaintyCoLFA
4
End Users Industry
PharmaceuticalFood ProcessingChemical Industries
Use Cases of Wet Granulators in Pharmaceutical Manufacturing & Food Processing
Pharmaceutical Manufacturing : In pharmaceutical manufacturing, wet granulators such as high‑shear wet granulators and fluid bed granulators are predominantly used to produce uniform, dust‑free granules for solid dosage forms like tablets and capsules. These machines mix powders with binders to enhance flowability, compressibility, and content uniformity, critical for tablet integrity and dose accuracy. Wet granulation ensures consistent dissolution and reduced manufacturing defects, improving bioavailability and regulatory compliance. Key market players like GEA Group, Glatt GmbH, and Romaco Group lead with advanced fluid bed and high‑shear systems that integrate granulation, drying, and process control, strengthening their positions through global service networks and innovation in continuous processing.
Food Processing : In the food processing sector, wet granulators such as fluid bed wet granulators and high‑shear granulators are widely applied to produce free‑flowing granules from powders like instant coffee, dairy powders, flavourings, and nutritional supplements. These systems improve solubility, reduce dust, and achieve consistent particle size, enhancing quality, handling, and shelf life. For example, fluid bed granulation enhances uniform binder distribution and allows simultaneous drying, making it ideal for soluble food products. Industry leaders such as Glatt GmbH deliver fluid bed solutions tailored for food‑grade operations, combining hygienic design with precise control to meet stringent food safety standards.
Chemical Industry : In chemical applications, wet granulators like twin‑screw wet granulators and fluid bed granulators convert fine powders into consistent granules used in detergents, catalysts, pigments, and specialty chemicals. This process improves particle uniformity, flow characteristics, and handling safety while reducing dust and segregation during packaging or downstream processing. Manufacturers benefit from robust, scalable equipment that can manage diverse chemistries and viscosity ranges. Prominent wet granulation equipment suppliers including GEA Group and Glatt GmbH support the chemical sector with modular granulation and drying platforms, leveraging global engineering expertise to optimise throughput and ensure stable production performance.
Impact of Industry Transitions on the Wet Granulators Market
As a core segment of the Production Tools & Equipment industry,
the Wet Granulators market develops in line with broader industry shifts.
Over recent years, transitions such as Transition from Batch Pharmaceutical Processing to Continuous Granulation Manufacturing Systems and Transition from Conventional Pharmaceutical Applications to Nutraceutical and Functional Ingredient Processing have redefined priorities
across the Production Tools & Equipment sector,
influencing how the Wet Granulators market evolves in terms of demand, applications and competitive dynamics.
These transitions highlight the structural changes shaping long-term growth opportunities.
01
Transition from Batch Pharmaceutical Processing to Continuous Granulation Manufacturing Systems
A significant transition in the wet granulators market is the shift from traditional batch processing to continuous manufacturing systems in pharmaceutical production. Pharmaceutical companies are increasingly adopting continuous wet granulation technologies to improve production efficiency, ensure consistent product quality, and reduce manufacturing downtime. Regulatory agencies are also encouraging advanced manufacturing approaches that enhance process control and product traceability. For example, several large pharmaceutical manufacturers are integrating continuous granulators with automated tablet production lines to streamline drug manufacturing. This transition is influencing equipment suppliers to develop integrated granulation systems that support real time monitoring and scalable production for high volume pharmaceutical operations.
02
Transition from Conventional Pharmaceutical Applications to Nutraceutical and Functional Ingredient Processing
Another notable transition is the expanding use of wet granulators beyond traditional pharmaceutical manufacturing into nutraceutical and functional food production. As demand for dietary supplements, protein powders, and fortified health products increases, manufacturers are adopting wet granulation techniques to improve powder stability, flowability, and dosing consistency. For instance, nutraceutical producers are using wet granulators to produce uniform granules for vitamin tablets and instant nutritional drink formulations. This shift is encouraging equipment manufacturers to design compact and flexible granulation systems suitable for smaller production facilities, enabling new market opportunities in the rapidly growing health and wellness product industry.